News

The court ruled in favor of Novo Nordisk and the FDA, rejecting a compounding pharmacy group's attempt to stop the FDA's ...
A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.
Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...
Dr William Li, whose book Eat to Beat Your Diet is a New York Times bestseller, says the most dangerous type of fat is ...
Many people experience a serious return of appetite, cravings and weight after coming off Ozempic, and having read far too ...